Submitted by Anonymous (not verified) on 8 May 2026 - 10:32
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 20, Status: Authorised